Literature DB >> 3580577

Spectrin Nice (beta 220/216): a shortened beta-chain variant associated with an increase of the alpha I/74 fragment in a case of elliptocytosis.

B Pothier, L Morlé, N Alloisio, M T Ducluzeau, C Caldani, C Féo, M Garbarz, I Chaveroche, D Dhermy, M C Lecomte.   

Abstract

We describe a new spectrin variant with a truncated beta-chain. It was discovered in a 17-year-old white boy presenting with intermittent jaundice and spleen enlargement. He also displayed numerous smooth elliptocytes. On sodium dodecyl sulfate-polyacrylamide gel, the truncated beta-chain (beta'-chain) appeared as an additional band of approximately 216 kilodaltons, migrating between spectrin beta-chain and ankyrin. It represented 30% of total beta-chain. The beta'-chain reacted with an antispectrin beta-chain monoclonal antibody. It failed to become phosphorylated when ghosts were incubated in the presence of [gamma-32P] adenosine triphosphate. Whole spectrin tetramerization was defective since the amount of spectrin dimer was increased in spectrin crude extract and the association constant of the spectrin dimer self-association was decreased. Spectrin whole tetramer isolated from spectrin crude extracts contained small quantities of beta'-chain. Spectrin tryptic peptides showed an increase of the 74,000-dalton fragment at the expense of the 80,000-dalton fragment. So far, the latter abnormality has been used to characterize a number of cases of hereditary elliptocytosis or pyropoikilocytosis with no other apparent change. In the present case, we consider that the abnormality is a consequence of the beta-chain alteration. The parents seemed asymptomatic. As a result, we regard this new spectrin variant as deriving from a de novo mutation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3580577

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Homozygous 4.1(-) hereditary elliptocytosis associated with a point mutation in the downstream initiation codon of protein 4.1 gene.

Authors:  N Dalla Venezia; F Gilsanz; N Alloisio; M T Ducluzeau; E J Benz; J Delaunay
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Spectrin Rouen (beta 220-218), a novel shortened beta-chain variant in a kindred with hereditary elliptocytosis. Characterization of the molecular defect as exon skipping due to a splice site mutation.

Authors:  M Garbarz; W T Tse; P G Gallagher; C Picat; M C Lecomte; F Galibert; D Dhermy; B G Forget
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

3.  Two elliptocytogenic alpha I/74 variants of the spectrin alpha I domain. Spectrin Culoz (GGT----GTT; alpha I 40 Gly----Val) and spectrin Lyon (CTT----TTT; alpha I 43 Leu---Phe).

Authors:  L Morlé; A F Roux; N Alloisio; B Pothier; J Starck; L Denoroy; F Morlé; R C Rudigoz; B G Forget; J Delaunay
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

4.  Two distinct variants of erythrocyte spectrin beta IV domain.

Authors:  B Pothier; N Alloisio; L Morlé; J Maréchal; H Barthélemy; M T Ducluzeau; A Dorier; J Delaunay
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

5.  A common type of the spectrin alpha I 46-50a-kD peptide abnormality in hereditary elliptocytosis and pyropoikilocytosis is associated with a mutation distant from the proteolytic cleavage site. Evidence for the functional importance of the triple helical model of spectrin.

Authors:  P G Gallagher; W T Tse; T Coetzer; M C Lecomte; M Garbarz; H S Zarkowsky; A Baruchel; S K Ballas; D Dhermy; J Palek
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

6.  Point mutation in the beta-spectrin gene associated with alpha I/74 hereditary elliptocytosis. Implications for the mechanism of spectrin dimer self-association.

Authors:  W T Tse; M C Lecomte; F F Costa; M Garbarz; C Feo; P Boivin; D Dhermy; B G Forget
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

7.  Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte beta-spectrin gene.

Authors:  P G Gallagher; S A Weed; W T Tse; L Benoit; J S Morrow; S L Marchesi; N Mohandas; B G Forget
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.